Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Automatic Data Processing Inc

Start price
Target price
Perf. (%)
€127.42
13.10.20
€170.00
04.11.21
54.07%
05.11.21

Editas Medicine Inc

Start price
Target price
Perf. (%)
€27.82
13.10.20
€24.30
04.11.21
-6.72%
04.11.20

buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€23.20
13.10.20
€19.20
04.11.21
-28.28%
22.12.20

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Tui AG

Start price
Target price
Perf. (%)
€31.11
13.10.20
€30.00
04.11.21
39.79%
09.11.20

EBIT growth >5% per year expected
Fair valuation
Lower EBIT Margin than peer group
Very low/no dividend yield expected
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.76
13.10.20
€2.90
28.10.20
-8.43%
28.10.20

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
NIO Inc. ADR

Start price
Target price
Perf. (%)
€18.25
13.10.20
€34.00
04.11.21
105.59%
05.11.21

Probably not worthwhile Investment
buy
Visteon Corporation

Start price
Target price
Perf. (%)
€69.00
13.10.20
€107.00
04.11.21
55.07%
05.11.21

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€68.20
13.10.20
-
04.11.21
17.30%
05.11.21

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€126.58
13.10.20
-
04.11.21
12.20%
05.11.21

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€236.45
13.10.20
€250.00
04.11.21
4.67%
05.11.20

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€465.15
13.10.20
€500.00
04.11.21
2.52%
21.01.21

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Adyen NV ADR

Start price
Target price
Perf. (%)
€34.00
13.10.20
€35.00
04.11.21
7.06%
12.12.20

Revenue growth >5% per year expected
Valuable balance sheet
Capable Management
buy
Adyen NV

Start price
Target price
Perf. (%)
€1,717.0
13.10.20
€2,000.0
04.11.21
6.58%
11.12.20

buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€16.10
13.10.20
€20.00
04.11.21
13.66%
05.11.20

Undervalued
ROE higher than 15% per year
Revenue growth > 30% per year expected
Small Risks for its business
buy
Do & Co AG

Start price
Target price
Perf. (%)
€36.90
13.10.20
€40.00
04.11.21
11.11%
09.11.20

Risky Investment
buy
CSX Corp.

Start price
Target price
Perf. (%)
€22.74
13.10.20
-
04.11.21
8.19%
18.12.20

buy
Glu Mobile Inc.

Start price
Target price
Perf. (%)
€6.97
13.10.20
-
04.11.21
49.02%
22.02.21

buy
Surface Oncology Inc.

Start price
Target price
Perf. (%)
€7.15
13.10.20
€8.00
18.10.20
9.09%
18.10.20

buy
Canacol Energy Ltd.

Start price
Target price
Perf. (%)
€10.90
13.10.20
€14.00
04.11.21
14.68%
05.11.21

buy
Westwater Resources Inc.

Start price
Target price
Perf. (%)
€5.48
13.10.20
€11.00
19.10.20
-11.72%
19.10.20

Infineon Technologies ADR

Start price
Target price
Perf. (%)
€26.60
13.10.20
€27.00
16.10.20
3.01%
16.10.20

buy
Infineon Technologies AG

Start price
Target price
Perf. (%)
€27.41
13.10.20
€29.00
04.11.21
-1.73%
11.11.20

Known brand
Future proof or reliable business model
Risky Investment
Low dividend yield expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.89
13.10.20
-
04.11.21
14.74%
21.06.21

buy
Carparts.com Inc.

Start price
Target price
Perf. (%)
€10.50
13.10.20
€12.00
04.11.21
28.57%
05.11.21

buy
Ernst Russ AG

Start price
Target price
Perf. (%)
€0.60
13.10.20
€0.80
04.11.21
630.00%
05.11.21